Nephrolyx

KidneyMetrix

The company develops an artificial intelligence platform using non-invasive sampling to provide early diagnostic insights for kidney injuries to healthcare providers.

GLX Analytix

This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.

Nephris

The company develops therapies for chronic kidney disease in diabetic patients.

Proton Intelligence

This company develops a wearable continuous potassium monitoring platform for clinicians to manage patients with chronic kidney disease and heart failure.

Nanocept

This company combines nanotechnology and diagnostics to enable early disease detection and support clinical decision-making for healthcare providers.

Molecular Warehouse

This company develops smartphone-enabled biosensor devices that allow transplant and dialysis patients to monitor drug levels and biomarkers from home for clinical review.

Nimble Dx

This company develops a non-invasive medical device for clinicians to monitor and diagnose complications in patients with implanted cardiovascular stents.

Early

Early develops home diagnostic devices for patients to screen for biomarkers and monitor conditions like kidney disease and cardiovascular disease from their own home.